Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign ...

Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was ...

Abbott Laboratories had a solid Q3, reporting 4.9% growth to outpace the consensus forecast despite the impact of lower COVID ...

Abbott Laboratories reported Q3 sales of $10.64 billion, driven by 8.2% organic growth in medical devices. Adjusted EPS for ...

On October 18, 2024, Abbott Laboratories Employees Credit Union (“ALEC”) filed a notice of data breach with the Attorney ...

Abbott Laboratories ABT will release its quarterly earnings report on Wednesday, 2024-10-16. Here's a brief overview for ...

Bernstein analyst Lee Hambright maintained a Buy rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target ...